Found: 10
Select item for more details and to access through your institution.
Pregnancy in patients with myelofibrosis: Mayo–Florence series of 24 pregnancies in 16 women.
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 1, p. 133, doi. 10.1111/bjh.17626
- By:
- Publication type:
- Article
A randomized phase II trial of two dosage levels of letrozole as third-line hormonal therapy for women with metastatic breast carcinoma.
- Published in:
- 1997
- By:
- Publication type:
- journal article
Malignant fibrous histiocytoma of the lung: Report of four cases and review of the literature.
- Published in:
- Cancer (0008543X), 1996, v. 78, n. 12, p. 2492, doi. 10.1002/(SICI)1097-0142(19961215)78:12<2492::AID-CNCR7>3.0.CO;2-M
- By:
- Publication type:
- Article
A phase I clinical and pharmacokinetic study of CS-682 administered orally in advanced malignant solid tumors.
- Published in:
- Investigational New Drugs, 2006, v. 24, n. 4, p. 327, doi. 10.1007/s10637-006-5392-0
- By:
- Publication type:
- Article
The burden of fatigue and quality of life in myeloproliferative disorders (MPDs)The authors of this article contributed as follows: Ruben A. Mesa, MD (designed trial, wrote manuscript); Joyce Niblack, JD (designed trial, wrote manuscript); Martha Wadleigh, MD (designed trial, reviewed/revised manuscript); Srdan Verstovsek, MD (designed trial, reviewed/revised manuscript); John Camoriano, MD (designed trial, reviewed/revised manuscript); Sunni Barnes, PhD (statistical design, administration of survey); Angelina D. Tan (statistical analysis, wrote manuscript); Pamela J. Atherton (statistical analysis, wrote manuscript); Jeff A. Sloan, PhD (statistical analysis, wrote manuscript); Ayalew Tefferi, MD (designed trial, wrote manuscript): An international internet‐based survey of 1179 MPD patients
- Published in:
- Cancer (0008543X), 2007, v. 109, n. 1, p. 68, doi. 10.1002/cncr.22365
- By:
- Publication type:
- Article
A phase 2 study of lenalidomide, rituximab, cyclophosphamide, and dexamethasone (LR-CD) for untreated low-grade non-Hodgkin lymphoma requiring therapy.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 5, p. 467, doi. 10.1002/ajh.24693
- By:
- Publication type:
- Article
Long-term results of the phase II trial of the oral mTOR inhibitor everolimus (RAD001) in relapsed or refractory Waldenstrom Macroglobulinemia.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 3, p. 237, doi. 10.1002/ajh.23620
- By:
- Publication type:
- Article
The clinical spectrum of Castleman's disease.
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 11, p. 997, doi. 10.1002/ajh.23291
- By:
- Publication type:
- Article
International working group for myelofibrosis research and treatment response assessment and long-term follow-up of 50 myelofibrosis patients treated with thalidomide-prednisone based regimens.
- Published in:
- American Journal of Hematology, 2011, v. 86, n. 1, p. 96, doi. 10.1002/ajh.21892
- By:
- Publication type:
- Article
Clearance of the Janus kinase 2 ( JAK2) V617F mutation after allogeneic stem cell transplantation in a patient with myelofibrosis with myeloid metaplasia.
- Published in:
- American Journal of Hematology, 2007, v. 82, n. 5, p. 400, doi. 10.1002/ajh.20832
- By:
- Publication type:
- Article